|
🐢
|
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
G. A. Schellekens,
B. Jong,
F. Hoogen,
L. Putte,
W. Venrooij
|
10 |
1998 |
10
🐢
|
|
🐜
|
Autoantigen microarrays for multiplex characterization of autoantibody responses
20 auth.
W. Robinson,
Carla DiGennaro,
W. Hueber,
B. Haab,
M. Kamachi,
E. J. Dean,
S. Fournel,
Derek A. Fong,
M. Genovese,
H. N. D. Vegvar,
...
K. Skriner,
D. Hirschberg,
R. Morris,
S. Muller,
G. Pruijn,
W. Venrooij,
J. Smolen,
P. Brown,
L. Steinman,
P. Utz
|
9 |
2002 |
9
🐜
|
|
🐜
|
Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.
8 auth.
F. Gaalen,
S. Linn-Rasker,
W. Venrooij,
B. D. Jong,
F. Breedveld,
C. Verweij,
...
R. Toes,
T. Huizinga
|
9 |
2004 |
9
🐜
|
|
🐢
|
Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages
9 auth.
E. Vossenaar,
T. Radstake,
A. Heijden,
M. A. M. V. Mansum,
Cindy E. J. Dieteren,
D. Rooij,
...
P. Barrera,
Albert J. W. Zendman,
W. Venrooij
|
8 |
2004 |
8
🐢
|
|
🐬
|
Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire.
R. D. Wildt,
R. Hoet,
W. Venrooij,
I. Tomlinson,
Greg Winter
|
7 |
1999 |
7
🐬
|
|
🐬
|
The human U1 snRNP-Specific U1A protein inhibits polyadenylation of its own pre-mRNA
W. Boelens,
E. Jansen,
W. Venrooij,
R. Stripecke,
I. Mattaj,
S. Gunderson
|
7 |
1993 |
7
🐬
|
|
🐜
|
Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis.
8 auth.
C. Reparon‐Schuijt,
W. V. Esch,
C. Kooten,
G. A. Schellekens,
B. Jong,
W. Venrooij,
...
F. Breedveld,
C. Verweij
|
7 |
2001 |
7
🐜
|
|
🐜
|
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.
19 auth.
E. M. Tan,
J. Smolen,
J. Mcdougal,
B. Butcher,
D. Conn,
R. Dawkins,
M. Fritzler,
T. Gordon,
J. Hardin,
J. Kalden,
...
R. Lahita,
R. Maini,
N. Rothfield,
R. Smeenk,
Y. Takasaki,
W. Venrooij,
A. Wiik,
Merlin R. Wilson,
J. Koziol
|
7 |
1999 |
7
🐜
|
|
🐬
|
Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.
Albert J. W. Zendman,
W. Venrooij,
G. Pruijn
|
7 |
2006 |
7
🐬
|
|
🐢
|
Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis
R. Mediwake,
D. Isenberg,
G. A. Schellekens,
W. Venrooij
|
7 |
2001 |
7
🐢
|
|
🦁
|
On the association of mRNA with the cytoskeleton in uninfected and adenovirus-infected human KB cells.
W. Venrooij,
P. Sillekens,
C. V. Eekelen,
R. J. Reinders
|
6 |
1981 |
6
🦁
|
|
🐢
|
Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis
E. Vossenaar,
W. Venrooij
|
6 |
2004 |
6
🐢
|
